Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1/2 13Phase 1 13Phase NA 2Phase EARLY_PHASE1 2Phase 3 1Phase 2/3 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Breast Neoplasms 433Neoplasms 371Prostatic Neoplasms 206Lung Neoplasms 195Colorectal Neoplasms 151Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 74Brain Neoplasms 69Ovarian Neoplasms 65Carcinoma, Hepatocellular 53Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 43Hematologic Neoplasms 42Depression 41Melanoma 37Glioma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 34Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Interventions

fludarabine 1Thiotepa 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelomonocytic, Chronic × 90 days × Clear all
NCT07588594 2026-05-26

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

Peking University People's Hospital

Phase NA Recruiting
31 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT04953312 2026-03-12

CALPRO

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡